Thinking About Endotypes when Managing Asthma

Medical experts discuss their approach to characterizing asthma, whether they employ a dichotomous classification based on eosinophilic (EOS) or non-eosinophilic driven inflammation, or consider multiple endotypes simultaneously.

EP: 1.External Factors and Seasonality of Asthma

EP: 2.Endotypes and Phenotypes in Asthma

EP: 3.Type 2 Inflammation and Biomarkers in Asthma

EP: 4.Moderate/Severe/Uncontrolled Asthma Classification

Now Viewing

EP: 5.Thinking About Endotypes when Managing Asthma

Thinking About Endotypes when Managing Asthma

EP: 1.External Factors and Seasonality of Asthma

EP: 2.Endotypes and Phenotypes in Asthma

EP: 3.Type 2 Inflammation and Biomarkers in Asthma

EP: 4.Moderate/Severe/Uncontrolled Asthma Classification

EP: 5.Thinking About Endotypes when Managing Asthma

EP: 6.Use of Oral Corticosteroids in Asthma

EP: 7.High Oral Corticosteroid Dose and Exposure in Asthma

EP: 8.Oral Corticosteroid Overuse and Uncontrolled Asthma

EP: 9.Biomarkers and Eosinophil Levels in Severe or Uncontrolled Asthma

EP: 10.Biologics in Asthma

EP: 11.GINA Guidelines and Biologics for Treatment of Asthma

EP: 12.Use of Biologics for Asthma in Patients with Allergies

EP: 13.Treatment of Asthma in Pediatric Patients

EP: 14.Atopic March in Pediatric Patients

EP: 15.Use of Biologics in Pediatric Patients and Conversations with Parents

EP: 16.Biologic Options in Pediatric Asthma

EP: 17.Advice for Clinicians Managing Asthma